Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Seyitler Kimyanayi AS's Enterprise Value is ₺554.0 Mil.
Seyitler Kimyanayi AS's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₺63.4 Mil. Therefore, Seyitler Kimyanayi AS's EV-to-FCF for today is 8.74.
The historical rank and industry rank for Seyitler Kimyanayi AS's EV-to-FCF or its related term are showing as below:
IST:SEYKM'
s EV-to-FCF Range Over the Past 10 Years
Min: -774.71 Med: -4.04 Max: 404.26
Current: 9.72
During the past 11 years, the highest EV-to-FCF of Seyitler Kimyanayi AS was 404.26. The lowest was -774.71. And the median was -4.04.
IST:SEYKM's EV-to-FCF is ranked better than 82.01% of 417
companies
in the Medical Devices & Instruments industry
Industry Median: 22.87
vs IST:SEYKM: 9.72
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Seyitler Kimyanayi AS (IST:SEYKM) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Seyitler Kimyanayi AS's PE Ratio (TTM) for today is calculated as:
Seyitler Kimyanayi AS's share price for today is ₺4.12.
Seyitler Kimyanayi AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺0.050.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Seyitler Kimyanayi AS's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Seyitler Kimyanayi AS EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Seyitler Kimyanayi AS's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Seyitler Kimyanayi AS's EV-to-FCF falls into.
Seyitler Kimyanayi AS's current Enterprise Value is ₺554.0 Mil.
Seyitler Kimyanayi AS's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺63.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Seyitler Kimyanayi AS (IST:SEYKM) has a EV-to-FCF of 8.74 as of Sep. 17, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Seyitler Kimyanayi AS and its competitors. According to the industry distribution chart, Seyitler Kimyanayi AS ranks #75 out of 417 companies in the Medical Devices & Instruments industry, placing it in the top 18%.
Is Seyitler Kimyanayi AS's EV-to-FCF too high?
Seyitler Kimyanayi AS's current EV-to-FCF is 8.74. The Medical Devices & Instruments industry median EV-to-FCF is 22.87. Seyitler Kimyanayi AS's value of 8.74 is 61.8% below this industry median. Based on the distribution chart, Seyitler Kimyanayi AS ranks #75 out of 417 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Seyitler Kimyanayi AS has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Seyitler Kimyanayi AS's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Seyitler Kimyanayi AS ranks #75 out of 417 companies for EV-to-FCF. This places Seyitler Kimyanayi AS in the top 18% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 22.87. Seyitler Kimyanayi AS's value of 8.74 is 61.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.87, based on 417 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Seyitler Kimyanayi AS's current EV-to-FCF of 8.74 is 61.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Seyitler Kimyanayi AS and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Seyitler Kimyanayi AS's current EV-to-FCF is 8.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seyitler Kimyanayi AS stock overvalued right now?
Based on GuruFocus' analysis, Seyitler Kimyanayi AS (IST:SEYKM) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺2.68, compared to a current price of ₺4.12 — trading 53.7% above its estimated fair value. The current EV-to-FCF is 8.74 and 61.8% below the Medical Devices & Instruments industry median of 22.87. Seyitler Kimyanayi AS's overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Seyitler Kimyanayi AS (IST:SEYKM), the current EV-to-FCF is 8.74 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Seyitler Kimyanayi AS (IST:SEYKM) Overvalued in 2026?
Based on GuruFocus' analysis, Seyitler Kimyanayi AS stock appears to be overvalued.
The current stock price of ₺4.12 is trading 53.7% above its estimated GF Value™ of ₺2.68.
GuruFocus considers Seyitler Kimyanayi AS to be Significantly Overvalued.
Key valuation signals for IST:SEYKM:
EV-to-FCF: 8.74
GF Value™: ₺2.68 vs. price of ₺4.12 (53.7% above fair value)
Industry Position: 61.8% below the Medical Devices & Instruments median (#75 of 417)
No single metric tells the full story. See the IST:SEYKM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Seyitler Kimya Sanayi AS is engaged in manufacturing Medical plaster, first aid plaster, and capsicum perforated rheumatism plaster. Its products include Medical Tapes, Medical fluids, Wound Dressing, First-Aid plaster and Eye products among others.
62GF Score
Get the complete analysis for IST:SEYKM
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:SEYKM has been successfully added to your 
